These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 2887440

  • 1. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ, Robinson SE, Rosecrans JA.
    Eur J Pharmacol; 1987 Jun 19; 138(2):265-8. PubMed ID: 2887440
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI, Murray TK, Green AR.
    Br J Pharmacol; 1993 Mar 19; 108(3):583-9. PubMed ID: 7682129
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD, Nichols DE, Yim GK.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2297-303. PubMed ID: 2886126
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine.
    Nencini P, Woolverton WL, Seiden LS.
    Brain Res; 1988 Aug 02; 457(1):136-42. PubMed ID: 2901895
    [Abstract] [Full Text] [Related]

  • 8. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats.
    Yeh SY, Hsu FL.
    Pharmacol Biochem Behav; 1991 Jul 02; 39(3):787-90. PubMed ID: 1723801
    [Abstract] [Full Text] [Related]

  • 9. Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
    Lowy MT, Nash JF, Meltzer HY.
    Eur J Pharmacol; 1989 Apr 12; 163(1):157-61. PubMed ID: 2472965
    [Abstract] [Full Text] [Related]

  • 10. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
    Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS.
    J Pharmacol Exp Ther; 1987 Apr 12; 241(1):338-45. PubMed ID: 2883295
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.
    Gazzara RA, Takeda H, Cho AK, Howard SG.
    Eur J Pharmacol; 1989 Sep 13; 168(2):209-17. PubMed ID: 2575036
    [Abstract] [Full Text] [Related]

  • 12. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
    Matthews RT, Champney TH, Frye GD.
    Pharmacol Biochem Behav; 1989 Aug 13; 33(4):741-7. PubMed ID: 2575758
    [Abstract] [Full Text] [Related]

  • 13. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.
    Schmidt CJ, Black CK, Abbate GM, Taylor VL.
    Brain Res; 1990 Oct 08; 529(1-2):85-90. PubMed ID: 1980848
    [Abstract] [Full Text] [Related]

  • 14. Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.
    Stone DM, Merchant KM, Hanson GR, Gibb JW.
    Neuropharmacology; 1987 Dec 08; 26(12):1677-83. PubMed ID: 2893986
    [Abstract] [Full Text] [Related]

  • 15. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
    Stone DM, Stahl DC, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1986 Aug 22; 128(1-2):41-8. PubMed ID: 2875893
    [Abstract] [Full Text] [Related]

  • 16. 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain.
    Ricaurte GA, Finnegan KF, Nichols DE, DeLanney LE, Irwin I, Langston JW.
    Eur J Pharmacol; 1987 Jun 04; 137(2-3):265-8. PubMed ID: 2886355
    [Abstract] [Full Text] [Related]

  • 17. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
    Johnson M, Hanson GR, Gibb JW.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4085-93. PubMed ID: 2446629
    [Abstract] [Full Text] [Related]

  • 18. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.
    Koprich JB, Campbell NG, Lipton JW.
    Brain Res Dev Brain Res; 2003 Dec 30; 147(1-2):177-82. PubMed ID: 14741762
    [Abstract] [Full Text] [Related]

  • 19. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
    Kleven MS, Woolverton WL, Seiden LS.
    Brain Res; 1989 May 29; 488(1-2):121-5. PubMed ID: 2472850
    [Abstract] [Full Text] [Related]

  • 20. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices.
    Johnson MP, Hoffman AJ, Nichols DE.
    Eur J Pharmacol; 1986 Dec 16; 132(2-3):269-76. PubMed ID: 2880735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.